Banner Witcoff’s Mercedes Meyer will co-chair the 8th Annual Summit on Life Sciences IP Due Diligence on December 3-4 in Boston.
As co-chair, Mercedes will moderate the “Doomsday Session: Preparing for Patent Protection Loss” on December 4. During the session, the co-chairs will ask attendees to consider the question “what would we do without patents?”
Additionally, Mercedes will present “Utilizing Trade Secrets in IP Diligence Reviews to Get the Life Sciences Deal Done,” on December 4. The session will cover:
- Integrating review of trade secrets and policy into your due diligence
- Anticipating trade secret risk in the international supply chain, from employee knowledge and retention to digital usage and how this may impact portfolio worth
- Understanding the distinction between what is protected by the patent and what must be protected by trade secrets and how this factors into valuation and diligence reviews
You can find more information on the 8th Annual Summit on Life Sciences IP Due Diligence here.